Addiction Medicine
From the Journals
Minorities hit especially hard by overdose deaths during COVID
Expanding access to naloxone, fentanyl test strips, and treatments for substance use disorders to disproportionately affected populations is...
From the Journals
Urgent need for research into psychedelic therapy for older adults
Little is known about appropriate dosing, pharmacokinetics, and pharmacodynamics of psychedelics in older adults.
From the Journals
Psychiatrists’ views on psychoactive drugs clash with U.S. policy
Survey respondents viewed psilocybin and ketamine as similarly safe – and safer than methamphetamine and alprazolam.
Feature
How to identify and treat patients with substance use disorders
Doctors aren’t necessarily rewarded for the time it takes to develop a rapport with patients ... that leads to asking, “How much are you drinking...
Latest News
DOJ: Indiana nurses allowed controlled substances during opioid recovery
“This improvement will increase access to treatment resources, enabling more nurses to complete treatment and progress toward a safe return to...
From the Journals
Alcohol warning labels need updates to reflect harms: NEJM
The current warning is“so understated that it borders on being misleading.”
From the Journals
Stable, long-term opioid therapy safer than tapering?
The investigators compared three dosing strategies: abrupt withdrawal, gradual tapering, and continuation of the current stable dosage.
From the Journals
Psychedelic drug therapy a potential ‘breakthrough’ for alcohol dependence
The effects observed with psilocybin were “considerably larger” than those of currently approved treatments for alcohol use disorder.
From the Journals
Reducing alcohol intake may reduce cancer risk
Study suggests cancer risk can be meaningfully altered by changing the amount of alcoholic beverages consumed.
Latest News
Patients who engage in risky ‘chemsex’ benefit from appropriate treatment
Chemsex combines sex, drugs, and smartphones, and physicians know very little about it.
From the Journals
‘Shocking’ and persistent gap in treatment for opioid addiction
In all 50 states and Washington, D.C., past-year prevalence of opioid use disorder was greater than rates of medication use.